Primary Adrenal Malignancies (Updates in Surgery) (2025. 2024. x, 176 S. X, 176 p. 235 mm)

個数:

Primary Adrenal Malignancies (Updates in Surgery) (2025. 2024. x, 176 S. X, 176 p. 235 mm)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 152 p.
  • 言語 ENG
  • 商品コード 9783031623004

Full Description

Dissemination of knowledge is the best and only strategy capable of improving clinical management in rare and ultra-rare malignancies, including primary adrenal malignancies. It is preliminary to any further healthcare policy such as, for example, the centralization of cases in referral institutions.

Adrenal primary malignancies are probably the rarest among rare pathologies. This epidemiological consideration is at the origin of a vicious circle: the lack of preoperative diagnosis leads to inappropriate surgical procedures and to inadequate follow-up and systemic therapy strategies. Furthermore, when malignancy is recognized, the relative role of systemic, surgical, or other local ablative techniques is often misinterpreted. All this produces a negative impact on survival, also in patients who could have been cured with a correct therapeutic strategy.

This open access book provides a user-friendly exploration of these rare conditions, using a transversal approach common in modern precision medicine. The text covers various clinical aspects, including epidemiology, genetics, molecular medicine, imaging, and surgery. Guidelines for managing syndromic situations are provided. The book thoroughly addresses all the different surgical issues and emphasizes the importance of pathology in assessing prognosis. The pivotal role of medical oncologists in managing these patients is explored, along with alternative treatments such as nuclear medicine and radiotherapy. Finally, the book highlights the latest preclinical research and its implications for translational medicine.

Contents

1. Epidemiology, Presentation, Staging, and Prognostic Factors in Adrenocortical Carcinoma.- 2. Epidemiology, Presentation, Staging, and Prognostic Factors in Malignant Pheochromocytoma.- 3. Genetics and Molecular Biology of Adrenocortical Carcinoma.- 4. Genetics and Molecular Biology of Pheochromocytoma and Paraganglioma.- 5. Imaging in Adrenocortical Carcinoma and Malignant Pheochromocytoma.- 6. Management of Endocrine Syndromes Associated with Adrenocortical Carcinoma.- 7. Management of Hereditary Syndromes Associated with Pheochromocytoma/Paraganglioma.- 8. Adrenal Incidentaloma.- 9. Surgery for Adrenocortical Carcinoma.- 10. Adrenocortical Carcinoma with Vena Cava Involvement.- 11. Adrenocortical Carcinoma: the Posterior Minimally Invasive Approach.- 12. Surgery for Malignant Pheochromocytoma.- 13. Open or Laparoscopic Surgery in the Management of Adrenocortical Carcinoma?.- 14. Pathology of Adrenocortical Carcinoma and Malignant Pheochromocytoma.- 15. Medical Treatment in Advanced Adrenocortical Carcinoma.- 16. Integrated Approach in Locally Advanced, Oligometastatic or Recurrent Adrenocortical Carcinoma.- 17. Medical Treatment of Malignant Pheochromocytoma.- 18. Role of Radiotherapy in Adrenocortical Carcinoma and Pheochromocytoma.- 19. Radionuclide Treatment in Malignant Pheochromocytoma.- 20. Preclinic and Translational Research in Adrenal Malignancies.

最近チェックした商品